menu Search
Home > About Us > History

About Us

  • 1994-2000

    Dr. Huang Yadong, Chief Scientist of Tyran Technology Group , led the team to successfully use genetic engineering methods to produce recombinant antimicrobial peptides and apply them to green farming and skin anti-infection, advocating a new concept of repair and beauty.

  • 2001-2004

    Dr. Huang Yadong, Chief Scientist of TyranTechnology Group , participated in and successfully developed a new genetically engineered class I drug, rh-aFGF, and applied it to wound repair.

  • 2004-2006

    The combined application of animal collagen and growth factor has developed the first medical device product with a combination of drugs and devices in China.

  • 2009

    Guangzhou Jyran Biotechnology Co., Ltd., the first enterprise of TyranTechnology Group , was formally established, and the first fully automatic freeze-drying production line with a production capacity of more than 100 million pieces was established in China.

  • 2010

    Develop a new biotransdermal technology based on liposome encapsulation and nano-emulsion, and establish the e-commerce channel freeze-dried repair brand [Liprestide].

  • 2017

    Founded the [SMR] medical skin care brand, using the combination of "machinery + makeup" products, focusing on the repair of problematic skin.

  • 2017-2018

    Founded Tyran (Guangzhou) Biotechnology Co., Ltd.], entered the field of biomaterials and medical devices, and passed the certification of 13485.

  • 2019

    Participated in the formulation of the only group standard for freeze-dried skin care products in China, and promoted the inclusion of freeze-dried skin care products in the new national cosmetics classification catalog.

  • 2020

    [Guangdong TyranTechnology Group Co., Ltd.] was formally established, and plans to build an advanced manufacturing industrial park covering an area of 25 acres and a construction area of about 70,000 square meters.

  • 2021

    Founded Changsha Jyran Biotechnology Co., Ltd. And obtained the production license, and successfully passed the ISO13485 international quality management system certification. In addition, the company has been approved to hold 11 Class II medical device production registration certificates. The company is committed to building a modern production base for medical devices.

  • 2022

    It has been funded by the "Guangzhou Specialized and Special New Private Enterprise Support Program Cultivation Enterprise", "Guangdong Province Innovative Small and Medium-sized Enterprises", "Guangdong Province Specialized and Special New Small and Medium-sized Enterprises", "Guangdong Province Medical Beauty Materials and Functional Skin Care Products Engineering Technology Research Center", and "Guangdong Province Key Area R&D Program Project".

  • 2023

    Recombinant type III humanized collagen has been registered in the national NMPA for the master file of medical device raw materials, and more than 10 Class 1 medical device registration certificates have been approved, and a multi-center clinical study of Class II medical devices has been carried out.